Institutional investors adjust holdings in Gen Digital and Sutro Biopharma

Amundi reduced its stake in Gen Digital Inc. (NASDAQ:GEN) by selling 159,540 shares in the first quarter, leaving the firm with 4,152,345 shares, about 0.69% of the company and valued at roughly $78 million.

Perceptive Advisors LLC opened a new position in Sutro Biopharma Inc. (NASDAQ:STRO), buying 715,307 shares for an estimated $17.8 million, bringing its ownership to about 4.3% of the biotech firm.